#WhyWeDoResearch
This week, we got a tantalizing glimpse of the potential future of research as a collective phenomenon. We were participating in a #whywedoresearch Tweetchat on “How can the pharmaceutical industry…
This week, we got a tantalizing glimpse of the potential future of research as a collective phenomenon. We were participating in a #whywedoresearch Tweetchat on “How can the pharmaceutical industry…
God is in the details said Ludwig Mies vander Rohe, cautioning that bold thinking in architecture must be grounded in a fervent commitment to quality and details. When we consider…
In Accenture’s new report, “The Patient is IN,” www.accenture.com/us-en/patient-services-survey-pharma.aspx 85 percent of pharmaceutical companies surveyed plan to raise their investment in patient centric services in the next 18 months. When…
Rx4good announced today the appointments of Heidi Adams, as Chief Patient Advocate and Tamar Sekayan as Counselor, Health Industry Engagement, Rx4good West Coast. “We’re delighted that Heidi and Tamar have…
In today’s New York Times, Andrew Pollack reports on the FDA Advisory Committee “no” vote for a new treatment for Duchenne muscular dystrophy. This is the second time in recent…
Topline findings from a survey of more than 600 caregivers now available for download.
Learn More